News and Updates

Date:
February 10, 2022

Report on Hyaluronic Acid & Oligopeptides cocktail treatments through Dermoelectroporation

Dr. James Fulton, vivant Skin Care , Miami Florida, USA

 

Preliminary Study

To evaluate the safety, tolerability and effectiveness of transdermal delivery of a Hyaluronic Acid & Oligopeptides cocktail
for either facial lifting and finelines reduction purposes through Dermoelectroporation®.

Study Design

  • Delivered every 1 or 2 weeks for a total of 8
    treatments.
  • Oligopeptides with Hyaluronic acid gel (Vivant Skin
    Care) was delivered
  • Ultrapeel® Transderm® Ionto Meso System
  • Repeat ideally every 12 week

 

Materials and Methods

Materials

  1. Oligopeptides serum 10% Reduces Lines & Generates New Collagen
  2. Hyaluronic acid serum 1% Fills out the Dermis and Hydrates the Joints
  3. Ultrapeel® Transderm Ionto Meso® system from Mattioli Engineering

Methods

  • Transdermal delivery of the cocktail through Dermoelectroporation® technology:
  • 2 Steps Prodecure:
    • a) Microdermabrasion
    • b) Transdermal delivery of:
      Prepare solution using a 10cc syringe. Use 5cc’s per side of the face, concentrating on problematic areas like the cheeks and forehead at lateral brow line.
      Per 10cc syringe
      5cc Oligopeptides
  • Application of proper follow up at the end.

Results & Conclusions

  • Patients were treated with the following results: Patients drastically reduced inches in weeks.
  • Transdermal delivery is possible and safe with no contraindications reported.
  • all patients showed a good level of improvement and she was so happy with results.

Report on Hyaluronic Acid and oligopeptides cocktail treatment through Dermoelectroporation Pn. 55100200/E Mattioli Engineering All rights

ELEVATING DERMATOLOGICAL CARE

Stay connected with Sensus Healthcare for more news and updates. For inquiries or further information, please contact us.

IN THE NEWS

From Scalpel to SRT: Impact of Innovation on the Dermatology Industry